`

Agios Pharmaceuticals

Pharmaceutical Manufacturing

Specialities :
Biopharmaceuticals
Rare genetic diseases
Cellular metabolism
And hemolytic anemias
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$256.0M
size-icon Size
501 - 1000

Frequently Asked Questions About Agios Pharmaceuticals

What does Agios pharmaceuticals do?+

Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds we build with patient communities, healthcare professionals, partners and colleagues help elevate our thinking and propel our science to new heights. These connections, combined with our cellular metabolism expertise, have fueled the development and approval of our first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies. Were a company that cares about our work, each other, and the people who are counting...

What are Agios pharmaceuticals's specialties? +

Biopharmaceuticals,rare genetic diseases,cellular metabolism,and hemolytic anemias

What is Agios pharmaceuticals's industry? +

Agios pharmaceuticals operates in the Pharmaceutical manufacturing industry.

What is Agios pharmaceuticals's revenue? +

Agios pharmaceuticals's revenue is 11m - 100m

What is Agios pharmaceuticals's company size? +

Agios pharmaceuticals has 501 - 1000 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.